Download Health Identity STC 2010 Reykjavik

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

Transcript
Jean-Jérôme SARRASIN
Icare Institut / RFID Center, Sierre, Switzerland
Christian HAY
Medinorma Sàrl, Rolle, Switzerland
Michael SCHUMACHER
Philippe RICHARD
University of Applied Sciences Western Switzerland
HES-SO Valais, Sierre, Switzerland
June 2-4 : STC 2010 Conference Reykjavík

The challenges of self-medication

Identification technologies

Health-Identity Project

Use Cases

Conclusion
2
OMS
10% of medicines are counterfeit
Self-medication
Increasingly practiced
Need a tool
- Certification of an authentic product
- Manage risk by patient profile
Health Identity
B2C Tool consumer help

Partners
◦ E-Mediat Ltd
◦ Pharmacie Du Midi, Sion
=> Swiss drugs database
=> Scenarios
3

Increasing autonomy of patients in their medication

Development of Health Portals as Google Health
4
Challenge
Request
Authenticity
Serialised Identification
Drug Interactions
User’s profile
Reimbursement Status
User’s profile
Allergies
User’s profile
Mobile Access
Mobile / Smartphone
5
Source : G. Courtney, EFPIA, March 2010
6
Serialisation

Existing Technologies
◦ EAN-13

 GTIN (Global Trade Item Number)
◦ DataMatrix, containing
 GTIN
 Batch Number
 Expiration Date
 Unique serial number
◦ RFID


7


Recognition of the identifier
(DataMatrix or EAN-13) on the
package with mobile camera
Provides maximum information in
terms of user’s health profile
8





Product description with picture, recommended
retail price, reimbursement
Payable by basic health insurance
List of generic drugs
Instructions in the user’s own language
Contra-indications according to the user’s profile
(allergies, state of health,..)
9




Expiry date of product
Batch recall
“Low-Level” authentication to combat
counterfeiting
Traceability of the drug using EPCIS
10

Scenario Inderal-Ventolin
◦ Beta-blocker in Inderal reduces or negates the effect of the
Ventolin
11
12
13

Health-Identity to retrieve the custody
chain:
◦
◦
◦
◦
For serialised identification
List all the events along the supply chain
Provided the events have been captured
Deliver indication about suspect journey / origin
in the supply chain
15

User to scroll down
16

Events from
outgoing the
manufacturing site
down to the sale at
retail pharmacy
17



The potential of new mobile applications for
management of medical information is vast
Health-Identity illustrates how services offered on
the web and mobile communications complete
each other
Potential Market


Link to health portals (single
source of information, privacy
protection)
Major authentication projects
(EFPIA, CoE EDQM)
18
Jean-Jérôme Sarrasin
[email protected]
Christian Hay
[email protected]
19